Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

GeoVax Labs (GOVX) Operating Expenses (2016 - 2025)

Historic Operating Expenses for GeoVax Labs (GOVX) over the last 16 years, with Q3 2025 value amounting to $6.4 million.

  • GeoVax Labs' Operating Expenses fell 2627.06% to $6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.9 million, marking a year-over-year increase of 475.45%. This contributed to the annual value of $29.1 million for FY2024, which is 880.95% up from last year.
  • Per GeoVax Labs' latest filing, its Operating Expenses stood at $6.4 million for Q3 2025, which was down 2627.06% from $6.3 million recorded in Q2 2025.
  • In the past 5 years, GeoVax Labs' Operating Expenses registered a high of $13.9 million during Q4 2021, and its lowest value of $1.6 million during Q2 2021.
  • In the last 5 years, GeoVax Labs' Operating Expenses had a median value of $5.9 million in 2024 and averaged $5.7 million.
  • As far as peak fluctuations go, GeoVax Labs' Operating Expenses surged by 77547.15% in 2021, and later tumbled by 6126.53% in 2022.
  • Over the past 5 years, GeoVax Labs' Operating Expenses (Quarter) stood at $13.9 million in 2021, then crashed by 61.27% to $5.4 million in 2022, then skyrocketed by 42.81% to $7.7 million in 2023, then grew by 19.69% to $9.2 million in 2024, then crashed by 30.79% to $6.4 million in 2025.
  • Its Operating Expenses stands at $6.4 million for Q3 2025, versus $6.3 million for Q2 2025 and $7.0 million for Q1 2025.